Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001005477-04-002642
Filing Date
2004-07-14
Accepted
2004-07-14 15:40:16
Documents
2
Period of Report
2004-07-01

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 4 edgar123.html 4/A  
1 AMENDMENT TO FORM 4 edgar123.xml 4/A 4407
2 POWER OF ATTORNEY d60072_lebuhn.htm EX-24 9933
  Complete submission text file 0001005477-04-002642.txt   16523
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 222 S 15TH STREET SUITE 600 N OMAHA NE 68102
Business Address 222 S 15TH STREET SUITE 600 N OMAHA NE 68102
LEBUHN ROBERT (Reporting) CIK: 0001007931 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-12957 | Film No.: 04913826